For statistical analysis, the cases were divided into three groups: p-ERK-negative or focally positive tumours (n=39), tumours with positive pERK staining in less than 20% (n=43) and carcinomas with more than 20% positive tumour cells (n=47). The gene discussed is MAPK1; the disease is carcinoma.